Share
))
HBO and The Ringer's Bill Simmons hosts the most downloaded sports podcast of all time, with a rotating crew of celebrities, athletes, and media staples, as well as mainstays like Cousin Sal, Joe House, and a slew of other friends and family members who always happen to be suspiciously available.
…
continue reading
Manage episode 358848255 series 2933391
Content provided by SciPro. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by SciPro or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://staging.podcastplayer.com/legal.
In the second episode of the series focusing on the use of AI in drug discovery, Nick is joined by Quentin Perron; CSO of Iktos. Iktos are a French biotech for ligand-based and structure-based de novo drug design focusing on multi-parametric optimization.
Quentin Perron is a medicinal chemist by training. He holds a PhD in organometallic chemistry from the University of Geneva. During his post-doc fellowship at UCLA, he worked on the total synthesis of Brasillicardin A, a complex natural molecule known for having potent immunosuppressive activity. After working as a medicinal chemist in CNS indications at Laboratoires Servier, he switched to data science and chemoinformatics at Quinten, a company specialising in data science services. In 2016, with his business partners Yann Gaston-Mathé and Nicolas Do Huu, he co-founded Iktos, a start-up company developing AI technologies for new drug design. He is now the CSO of the company.
To speak to Nick, please drop an email to [email protected]
33 episodes
